Identification of candidate genes and pathways in retinopathy of prematurity by whole exome sequencing of preterm infants enriched in phenotypic extremes

Sang Jin Kim, Kemal Sönmez, Ryan Swan, J. Peter Campbell, Susan Ostmo, R.v. Paul Chan, Aaron Nagiel, Kimberly A. Drenser, Audina M. Berrocal, Jason Horowitz, Xiaohui Li, Yii‐Der Ida Chen, Kent D. Taylor, Charles F. Simmons, Jerome I. Rotter, Michael F. Chiang, Karyn Jonas, Osode Coki, Cheryl-Ann Eccles, Leora Sarna, Anton Orlin, Catherin I. Negron, Kimberly Denser, Kristi Cumming, Tammy Osentoski, Tammy Check, Mary Zajechowski, Thomas C. M. Lee, Evan Kruger, Kathryn McGovern, Raghu Murthy, Sharon Galvis, Kaye Roll, Jayashree Kalpathy-Cramer, Deniz Erdoğmuş, Stratis Ioannidis, María Ana Martinez-Castellanos, Samantha Salinas-Longoria, Rafael Romero, Andrea Arriola, Francisco Olguin-Manríquez, Miroslava Meraz-Gutierrez, Carlos M. Dulanto-Reinoso, Cristina Montero-MendozaScientific 2021 · DOI

Abstract

Retinopathy of prematurity (ROP) is a vasoproliferative retinal disease affecting premature infants. In addition to prematurity itself and oxygen treatment, genetic factors have been suggested to predispose to ROP. We aimed to identify potentially pathogenic genes and biological pathways associated with ROP by analyzing variants from whole exome sequencing (WES) data of premature infants. As part of a multicenter ROP cohort study, 100 non-Hispanic Caucasian preterm infants enriched in phenotypic extremes were subjected to WES. Gene-based testing was done on coding nonsynonymous variants. Genes showing enrichment of qualifying variants in severe ROP compared to mild or no ROP from gene-based tests with adjustment for gestational age and birth weight were selected for gene set enrichment analysis (GSEA). Mean BW of included infants with pre-plus, type-1 or type 2 ROP including aggressive posterior ROP (n = 58) and mild or no ROP (n = 42) were 744 g and 995 g, respectively. No single genes reached genome-wide significance that could account for a severe phenotype. GSEA identified two significantly associated pathways (smooth endoplasmic reticulum and vitamin C metabolism) after correction for multiple tests. WES of premature infants revealed potential pathways that may be important in the pathogenesis of ROP and in further genetic studies.

Introduction

Retinopathy of prematurity (ROP) remains a leading cause of childhood blindness globally. While clinical risk factors such as low birth weight (BW), early gestational age (GA), and oxygen therapy are well-established, they do not fully explain the clinical variability observed in neonatal intensive care units. Clinicians frequently encounter "phenotypic extremes": high-risk infants who do not develop significant disease, and low-risk infants who progress to aggressive, sight-threatening ROP.

This discrepancy strongly suggests a genetic predisposition. Previous research has largely focused on candidate genes involved in angiogenesis, but these have not fully accounted for the disease's complexity. This study utilizes an unbiased, exome-wide approach to identify the genetic architecture underlying ROP by focusing on these outlier cases.

Methods

The researchers employed a strategy of phenotypic enrichment, selecting 100 non-Hispanic Caucasian infants from the i-ROP consortium who represented the extremes of the clinical spectrum. The cohort consisted of 58 infants with severe ROP and 42 with mild or no ROP.

Study workflow including subject selection, sequencing, and analysis stages.

The technical pipeline involved:

  • Whole Exome Sequencing (WES): Performed on a BGISEQ-500 platform to identify protein-coding variants.
  • SKAT-O (Sequence Kernel Association Optimal Unified Test): A statistical method for gene-based testing that aggregates rare variants within a gene to increase power.
  • Gene Set Enrichment Analysis (GSEA): Used to identify biological pathways associated with the disease using databases like KEGG, PANTHER, and Reactome.
  • Statistical Adjustments: All analyses were adjusted for BW and GA to ensure the genetic signals were specific to ROP rather than general prematurity.

Results

While no single gene reached the strict threshold for genome-wide significance ($P < 2.5 \times 10^{-6}$), several candidate genes emerged with nominal associations.

Top candidate genes identified through gene-based analysis of rare variants.

As shown in the table above, genes such as RNF225, PMS1, and THSD4 were among the top-ranked candidates for rare variant associations.

The most significant findings came from the pathway analysis. Two biological pathways remained significant after rigorous correction for multiple testing:

  1. Smooth Endoplasmic Reticulum (GO:0005790): Involved in lipid and carbohydrate metabolism.
  2. Vitamin C (ascorbate) Metabolism (Reactome R-HSA-196836): Highlighting the potential role of antioxidant capacity.

Other pathways showing nominal significance ($P < 0.05$) included T cell activation, dopamine receptor signaling, and PDGF signaling.

Discussion

The findings suggest that ROP is a polygenic disease resulting from the cumulative effect of variants across multiple pathways rather than a single dominant mutation. The identification of metabolic and inflammatory pathways—specifically those related to the smooth endoplasmic reticulum and vitamin C—points toward cellular stress and antioxidant defense as critical factors in retinal health.

Interestingly, the nominal association of the $\beta$2 adrenergic receptor signaling pathway aligns with ongoing clinical interest in using beta-blockers to mitigate ROP progression.

Limitations and Future Directions

The study's primary limitation is its sample size of 100 infants, which, while significant for WES in this field, lacks the power of massive GWAS. Furthermore, the focus on non-Hispanic Caucasians to avoid population stratification means these results require validation in more diverse populations. Future work should include functional "wet lab" studies to validate these pathways and larger meta-analyses to achieve higher statistical confidence.

Summary updated

Abstract

Retinopathy of prematurity (ROP) is a vasoproliferative retinal disease affecting premature infants. In addition to prematurity itself and oxygen treatment, genetic factors have been suggested to predispose to ROP. We aimed to identify potentially pathogenic genes and biological pathways associated with ROP by analyzing variants from whole exome sequencing (WES) data of premature infants. As part of a multicenter ROP cohort study, 100 non-Hispanic Caucasian preterm infants enriched in phenotypic extremes were subjected to WES. Gene-based testing was done on coding nonsynonymous variants. Genes showing enrichment of qualifying variants in severe ROP compared to mild or no ROP from gene-based tests with adjustment for gestational age and birth weight were selected for gene set enrichment analysis (GSEA). Mean BW of included infants with pre-plus, type-1 or type 2 ROP including aggressive posterior ROP (n = 58) and mild or no ROP (n = 42) were 744 g and 995 g, respectively. No single genes reached genome-wide significance that could account for a severe phenotype. GSEA identified two significantly associated pathways (smooth endoplasmic reticulum and vitamin C metabolism) after correction for multiple tests. WES of premature infants revealed potential pathways that may be important in the pathogenesis of ROP and in further genetic studies.
BibTeX
@inproceedings{kim2021identification,
  author = {Sang Jin Kim and Kemal Sönmez and Ryan Swan and J. Peter Campbell and Susan Ostmo and R.V. Paul Chan and Aaron Nagiel and Kimberly A. Drenser and Audina M. Berrocal and Jason Horowitz and Xiaohui Li and Yii‐Der Ida Chen and Kent D. Taylor and Charles F. Simmons and Jerome I. Rotter and Michael F. Chiang and Michael F. Chiang and Susan Ostmo and Sang Jin Kim and Kemal Sönmez and J. Peter Campbell and R.V. Paul Chan and Karyn Jonas and Jason Horowitz and Osode Coki and Cheryl-Ann Eccles and Leora Sarna and Anton Orlin and Audina M. Berrocal and Catherin I. Negron and Kimberly Denser and Kristi Cumming and Tammy Osentoski and Tammy Check and Mary Zajechowski and Thomas C. M. Lee and Evan Kruger and Kathryn McGovern and Charles F. Simmons and Raghu Murthy and Sharon Galvis and Jerome I. Rotter and Ida Chen and Xiaohui Li and Kent D. Taylor and Kaye Roll and Jayashree Kalpathy-Cramer and Deniz Erdoğmuş and Stratis Ioannidis and María Ana Martinez-Castellanos and Samantha Salinas-Longoria and Rafael Romero and Andrea Arriola and Francisco Olguin-Manríquez and Miroslava Meraz-Gutierrez and Carlos M. Dulanto-Reinoso and Cristina Montero-Mendoza},
  title = {{Identification of candidate genes and pathways in retinopathy of prematurity by whole exome sequencing of preterm infants enriched in phenotypic extremes}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-021-83552-y},
}
Figure